Filing Flows › Edwards Lifesciences (EW) › Operating margin
Edwards Lifesciences (EW) operating margin by quarter
Edwards Lifesciences' operating margin was 17.4% in Q3 2026 (third quarter 2026), -12.0 pts from Q2 2026. Over the last 7 quarters it ranged from 9.6% (Q4 2025) to 29.5% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 17.4% | -12.0 pts | -2.3 pts |
| Q2 2026 | 29.5% | +0.5 pts | +2.6 pts |
| Q1 2026 | 29.0% | +19.3 pts | +1.0 pts |
| Q4 2025 | 9.6% | -10.1 pts | — |
| Q3 2025 | 19.8% | -7.1 pts | — |
| Q2 2025 | 26.8% | -1.1 pts | — |
| Q1 2025 | 27.9% | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' operating margin?
Edwards Lifesciences' operating margin was 17.4% in Q3 2026 (third quarter 2026), -12.0 pts from Q2 2026.
How has Edwards Lifesciences' operating margin changed?
Over the last 7 quarters it ranged from 9.6% (Q4 2025) to 29.5% (Q2 2026).